Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Jon C. Ogg | Jan 8, 2013 at 2:39 PM EST

Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit

ThinkstockAmgen Inc. (NASDAQ: AMGN) is holding up better than some investors might have expected after the biotech giant warned about…

Jon C. Ogg | Jan 7, 2013 at 12:42 PM EST

Celgene Guidance Brings All-Time Highs… What Lies Ahead

ThinkstockCelgene Corporation (NASDAQ: CELG) has issued some long-term guidance which appears to be at the high-end of its previous range.…

Jon C. Ogg | Jan 7, 2013 at 10:43 AM EST

Biotech and BioHealth Top Stocks on the Move (ACHN, CBMX, DNDN, EXAS, ILMN, PPHM, VVUS)

ThinkstockThere are big movers in the market just about every day, and these movers often come from biotech and other…

Jon C. Ogg | Jan 4, 2013 at 5:42 AM EST

12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)

It may seem hard to believe, but some stocks are expected to rise by 50%, 100%, or even more over…

Jon C. Ogg | Jan 3, 2013 at 9:04 AM EST

Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) is living up to why we just said it is now an overvalued biotech stock for 2013.…

Jon C. Ogg | Dec 24, 2012 at 11:52 AM EST

Alexza FDA Approval: Coal in the Christmas Stocking?

ThinkstockAlexza Pharmaceuticals, Inc. (NASDAQ: ALXA) is seeing its shareholders get nothing but coal for Christmas this year. The stock is…

Jon C. Ogg | Dec 20, 2012 at 2:57 PM EST

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

The largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in 2013.…

Jon C. Ogg | Dec 20, 2012 at 6:21 AM EST

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in…

Jon C. Ogg | Dec 18, 2012 at 10:43 AM EST

Is There Finally a Winner in the Crowded Obesity Drug Market?

ThinkstockAccording to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are…

Jon C. Ogg | Dec 18, 2012 at 9:35 AM EST

Analyst: Biogen Idec Gains Are Done

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) has had a great 2012. Actually, it has had a hell of a year with a gain…

Jon C. Ogg | Dec 18, 2012 at 8:11 AM EST

J.P. Morgan Sees More Upside in Hospital Stocks (CYH, HCA, LPNT, THC, UHS, HMA, VHS)

ThinkstockJ.P. Morgan Chase & Co. (NYSE: JPM) has issued a research call that calls for some very large upside in…

Paul Ausick | Dec 14, 2012 at 11:54 AM EST

Drug Maker Staging a Comeback After Yesterday’s Debacle

ThinkstockDrug developer Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) watched its shares plummet 35% yesterday following a report that rheumatoid arthritis treatment…

Paul Ausick | Dec 14, 2012 at 8:09 AM EST

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

ThinkstockBiotech giant Amgen Inc. (NASDAQ: AMGN) made a series of moves after markets closed last night that appear to add…

Jon C. Ogg | Dec 11, 2012 at 2:53 PM EST

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) is not getting any great warm welcome out of its 2012 investor meeting webcast.…

Jon C. Ogg | Dec 10, 2012 at 2:01 PM EST

J&J Gets Broader Use for Prostate Cancer Drug

ThinkstockJohnson & Johnson (NYSE: JNJ) may have an even larger winner with its prostate cancer drug called ZYTIGA. The Food…

1 … 309 310 311 312 313 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit

Celgene Guidance Brings All-Time Highs… What Lies Ahead

Biotech and BioHealth Top Stocks on the Move (ACHN, CBMX, DNDN, EXAS, ILMN, PPHM, VVUS)

12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)

Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec

Alexza FDA Approval: Coal in the Christmas Stocking?

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Is There Finally a Winner in the Crowded Obesity Drug Market?

Analyst: Biogen Idec Gains Are Done

J.P. Morgan Sees More Upside in Hospital Stocks (CYH, HCA, LPNT, THC, UHS, HMA, VHS)

Drug Maker Staging a Comeback After Yesterday’s Debacle

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

J&J Gets Broader Use for Prostate Cancer Drug

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Health and Healthcare Articles

All Health and Healthcare Articles

Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit

Celgene Guidance Brings All-Time Highs… What Lies Ahead

Biotech and BioHealth Top Stocks on the Move (ACHN, CBMX, DNDN, EXAS, ILMN, PPHM, VVUS)

12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)

Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec

Alexza FDA Approval: Coal in the Christmas Stocking?

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Is There Finally a Winner in the Crowded Obesity Drug Market?

Analyst: Biogen Idec Gains Are Done

J.P. Morgan Sees More Upside in Hospital Stocks (CYH, HCA, LPNT, THC, UHS, HMA, VHS)

Drug Maker Staging a Comeback After Yesterday’s Debacle

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

J&J Gets Broader Use for Prostate Cancer Drug

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation